Silveus Ins_bannerSpecial Edition 21_bannerBlynds_8-5-21Caldwell Livestock_11-1-21
Advertise With Us Subscribe Today Facebook
SouthernLivestock.com
Not a member? Membership has its privileges— Register today! • Make SLS your homepage!
home articles Herd Health |

Plan now for antibiotic changes on the horizon

published: November 17th 2021
by: Linda Geist
source: University of Missouri Extension

Plan now for antibiotic changes on the horizon

In 2023, antibiotics that are currently available over the counter will require a veterinarian’s prescription.

  • Published: Friday, Nov. 5, 2021

COLUMBIA, Mo. – While 2023 might seem a long way off, it’s not too early for livestock producers think about how recent Food and Drug Administration guidance might affect their operations, says University of Missouri Extension veterinarian Craig Payne.

On June 11, the FDA’s Center for Veterinary Medicine published Guidance for Industry No. 263(opens in new window) (GFI #263) in the Federal Register. The document outlines a strategy and timeline for bringing all medically important antibiotics that are currently available over the counter under veterinary oversight. This will affect several antibiotics familiar to livestock producers.

If you have a valid veterinarian-client-patient relationship (VCPR), the impact will be minimal because a veterinarian will be able to issue a prescription for these antibiotics, says Payne. If you don’t have a VCPR, now is the time to find a veterinarian willing to work with you to ensure future access to antibiotics.

Under a VCPR, a veterinarian must have sufficient knowledge of your operation to make medical judgments, he says. It also means you agree to follow the veterinarian’s instructions.

In 2017, many antibiotics used in the feed or drinking water of livestock moved from over-the-counter status to requiring a Veterinary Feed Directive or prescription. However, a small percentage remained available OTC in other forms, such as injectables, intramammary tubes and boluses, Payne says.

GFI #263 specifically addresses this small percentage. The FDA expects the labels of these remaining OTC antibiotics to display the following language by June 11, 2023: “Caution: federal law restricts this drug to use by or on the order of a licensed veterinarian.”

“This will end over-the-counter sales of antibiotics, and livestock owners will need a prescription from a veterinarian in the future if they want access to antibiotics,” Payne says.

He emphasizes that antibiotics won’t necessarily have to be purchased through a veterinarian, but a prescription will be required.

GFI #263 is available at www.fda.gov/media/130610/download(opens in new window).

More information from the FDA:

Examples of affected products

Cephapirin, cephapirin benzathine

  • Intramammary tubes: ToDAY and ToMORROW

Gentamicin

  • Injectables: Garasol, Gentamicin Piglet Injection

Lincomycin

  • Injectables: Lincomix 100, Lincomix 300, LincoMed 100, LincoMed 300

Oxytetracycline

  • Injectables: Liquamycin LA-200, Noromycin 300 LA, Bio-Mycin 200, Agrimycin 200, etc.
  • Boluses: Terramycin Scours Tablets, OXY 500 Calf Boluses

Penicillin G procaine, penicillin G benzathine

  • Injectables: Penicillin Injectable, Dura-Pen, Pro-Pen-G, Combi-Pen 48, etc.
  • Intramammary tubes: Masti-Clear, Go-dry, Albadry Plus

Sulfadimethoxine, sulfamethazine

  • Injectables: Di-Methox 40%, SulfMed 40%
  • Boluses: Albon, Sustain III Cattle & Calf Boluses, Supra Sulfa III Cattle & Calf Boluses

Tylosin

  • Injectables: Tylan 50, Tylan 200

Site:   Home   Publications   Market Reports   Sale Reports   Sale Calendar   Cattle & Service Directory   Full Commodities Report   Services   About Us   Contact Us

Article Categories:   All   Industry News   Herd Health   Feed & Nutrition   Pastures & Forages   Reproduction   Marketing   Columnists   Production   Genetics & Performance   Weather Forecast   Breed News   Producer Feature Stories   Items of Interest   New Products   Recipes

User:   Login   Logout   Register/Profile   Submit Market Report   Submit Sale Report